COPD Patients May Be at a Higher Risk of Osteoporosis and Fracture

Reviewed by Dr. Victor Marchione, MD.
Written by Emily Lunardo
Published on

COPD Patients May Be at a Higher...

Chronic obstructive pulmonary disease (COPD) patients may be at a higher risk of osteoporosis and fracture. Researchers of the study evaluated incidences of hip fractures and all major osteoporotic fractures among COPD patients and non-COPD patients. Researchers further evaluated the use and performance of fracture risk prediction tools in COPD patients to determine osteoporosis prevalence.

To complete the study, the researchers used electronic information collected from the UK population. Patients were over the age of 40 and control patients were matched by gender and age to each COPD patient.

The study uncovered that COPD patients had an increased risk of bone fractures compared to persons without COPD. There was also a higher prevalence of osteoporosis among COPD patients.

COPD patients have higher incidences of falls, which can increase the risk of fractures.

COPD is an umbrella term for a group of progressive lung diseases including emphysema, chronic bronchitis, and refractory (non-reversible) asthma. Patients with COPD experience breathlessness, coughing, wheezing, and tightness in the chest.

Risk factors of COPD include secondhand smoke exposure, smoking, exposure to occupational dust and chemicals, exposure to fumes or burning fumes, being older, and genetics.

Patients with COPD may not be able to be as active as non-patients, which can contribute to being overweight and being unable to strengthen one’s bones through activity, which are contributing factors to osteoporosis and weaker bones.

It’s essential that COPD patients work with their doctors to not only manage and treat COPD but any possible weak bones or osteoporosis as well.

Also read:

Related Reading:


On any matter relating to your health or well-being, please check with an appropriate health professional. No statement herein is to be construed as a diagnosis, treatment, preventative, or cure for any disease, disorder or abnormal physical state. The statements herein have not been evaluated by the Foods and Drugs Administration or Health Canada. Dr. Marchione and the doctors on the Bel Marra Health Editorial Team are compensated by Bel Marra Health for their work in creating content, consulting along with formulating and endorsing products.